We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAYO:NASDAQPayoneer Global Inc. Analysis

Data as of 2026-04-23 - not real-time

$4.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Payoneer (PAYO) trades around $4.90, just above its 20‑day SMA of $4.93 and 50‑day SMA of $4.89, indicating a tight price corridor. RSI sits near 48, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive and the signal line is bullish, hinting at modest upward momentum. The stock’s beta of 1.67 and 30‑day volatility of 45% signal a high‑risk profile relative to the market. Fundamentally, PAYO’s trailing P/E of 25.8 is well below the industry average of 37, and the forward P/E of 14.5 reflects accelerating earnings expectations. Revenue grew 5% YoY to $1.05 bn with an impressive 84% gross margin and a 12.5% operating margin, supporting a solid profitability base. Cash is strong at $416 m versus $72 m of debt, yielding a low debt‑to‑equity of 10%, though free cash flow is slightly negative. The DCF‑derived fair value of $8.91 implies a 53% upside from current levels, and analyst consensus rates the stock a “strong buy.” Upcoming Q1 2026 earnings on May 7 could serve as a catalyst, but decreasing volume and a neutral trend caution against aggressive short‑term moves. Overall, the blend of undervaluation, solid margins, and growth potential positions PAYO as an attractive medium‑ to long‑term play, albeit with heightened market and regulatory risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support with decreasing volume
  • Bullish MACD but neutral overall trend
  • High beta and volatility increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >50% upside
  • Strong margins and low debt support earnings growth
  • Upcoming earnings release may unlock valuation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable revenue growth in a global fintech market
  • Undervalued relative to peers and industry P/E
  • Diversified geographic exposure offsets some regulatory risk

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin6.95%
P/E Ratio25.8
ROE10.24%
ROA1.00%
Debt/Equity10.27
P/B Ratio2.4
Op. Cash Flow$233.5M
Free Cash Flow$-14377375
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI48.1
Support$4.38
Resistance$5.35
MA 20$4.93
MA 50$4.89
MA 200$5.83
MACDBullish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair Value$8.91
Target Price$7.50
Upside/Downside53.22%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.67
Volatility45.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.